Spectrum Management Group’s BioTelemetry, Inc. BEAT Stock Holding History

Spectrum Management Group’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,790	Closed	-$82K	–	295
2020 Q3	$82K	Hold	1,790	–	–	0.02%	128
2020 Q2	$81K	Hold	1,790	–	–	0.02%	124
2020 Q1	$69K	Hold	1,790	–	–	0.02%	113
2019 Q4	$83K	Hold	1,790	–	–	0.03%	128
2019 Q3	$73K	Hold	1,790	–	–	0.02%	130
2019 Q2	$86K	Hold	1,790	–	–	0.02%	132
2019 Q1	$112K	Hold	1,790	–	–	0.03%	103
2018 Q4	$107K	Hold	1,790	–	–	0.04%	95
2018 Q3	$115K	Buy	+1,790	New	+$99.9K	0.04%	99
2017 Q4	–	Sell	-15	Closed	–	–	478
2017 Q3	$0	Buy	+15	New	+$520	﹤0.01%	480

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Spectrum Management Group's BEAT Position: Q4 2020 in Review

Spectrum Management Group sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 1,790 shares — an estimated $82K sold.

Spectrum Management Group first reported a position in BEAT in Q3 2017 and held it in 10 quarters. The position peaked at $115K in Q3 2018. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

Spectrum Management Group reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
Spectrum Management Group sold 1,790 BioTelemetry, Inc. shares in Q4 2020, an estimated $82K.
Spectrum Management Group first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 10 quarters.
Spectrum Management Group's BioTelemetry, Inc. position peaked at $115K in Q3 2018.
238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Spectrum Management Group's 13F filing for Q4 2020, filed 9 Feb 2021.